Skip to main content
. 2022 Apr 27;30(2):227–234. doi: 10.5606/tgkdc.dergisi.2022.21595

Table 3. The comparison of changes of the outcomes between groups.

  PR group (n=33) Control group (n=33)  
Variables Median IQR Median IQR p
ARespiratory function test          
FEV1 (%) 0 -3-9 0 -2-5 0.430
FVC (%) 3 -1-10 2 -4-10 0.667
FEV1/FVC -1 -5-3 0 -5-3 0.979
A6-MWD (m) 60 30-85 0 -15-40 <0.001*
AMRC -1 -1-0 0 0-1 <0.001*
ASGRQ          
Symptom -7 -17-2 0 -3-4 0.067
Activity -7 -25-0 0 -6-1 0.006*
Impact -8 -17-1 0 -2-3 0.028*
Total -7 -17-0 0 -20-18 0.074
ASF-36          
Physical function 15 0-30 0 0-8 0.008*
Social functioning 0 -13-25 0 0-0 0.699
Role physical 0 0-50 0 -13-13 0.190
Role emotional 0 0-40 0 0-17 0.412
General health 4 -1-13 0 -5-0 0.062
Mental health 8 0-21 0 0-6 0.067
Bodily pain 0 0-21 0 0-0 0.106
Vitality 8 0-20 0 -5-0 0.006*
AHAD subscales          
Anxiety 0 -2-1 0 -2-1 0.032
Depression -1 -2-2 0 -2-0 0.550
PR: Pulmonary rehabilitation; IQR: Interquartile range; FEV1: Forced expiratory volume in the first second; FVC: Forced vital capacity; 6-MWD: 6 Minutes Walk Distance; mMRC: Modified Medical Research Council Dyspnea Scale; SGRQ: St. George’s Respiratory Questionnaire; SF-36: Short-Form Health Survey; HAD: Hospital Anxiety and Depression Scale; Results are shown as change Δ between post-treatment and baseline levels; * p<0.05.